147 related articles for article (PubMed ID: 11396631)
21. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III.
Stachura J; Krzeszowiak A; Popiela T; Urbańczyk K; Pituch-Noworolska A; Wieckiewicz J; Zembala M
Pol J Pathol; 1999; 50(3):155-61. PubMed ID: 10624117
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma.
Yoo CH; Noh SH; Kim H; Lee HY; Min JS
J Surg Oncol; 1999 May; 71(1):22-8. PubMed ID: 10362087
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C
Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691
[TBL] [Abstract][Full Text] [Related]
24. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
25. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study.
Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM
Tumori; 2010; 96(6):971-7. PubMed ID: 21388061
[TBL] [Abstract][Full Text] [Related]
26. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence.
Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J
Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373
[TBL] [Abstract][Full Text] [Related]
27. Determination of prognosis in patients with prostate cancer treated with radical prostatectomy: prognostic value of CD44v6 score.
Ekici S; Ayhan A; Kendi S; Ozen H
J Urol; 2002 May; 167(5):2037-41. PubMed ID: 11956433
[TBL] [Abstract][Full Text] [Related]
28. CD44 splice variants as prognostic markers in colorectal cancer.
Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
[TBL] [Abstract][Full Text] [Related]
29. CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies.
Fang M; Wu J; Lai X; Ai H; Tao Y; Zhu B; Huang L
Cell Physiol Biochem; 2016; 40(3-4):567-578. PubMed ID: 27889771
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms.
Lee SC; Harn HJ; Lin TS; Yeh KT; Liu YC; Tsai CS; Cheng YL
Ann Thorac Surg; 2003 Jul; 76(1):213-8; discussion 218. PubMed ID: 12842543
[TBL] [Abstract][Full Text] [Related]
31. CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
Lu L; Huang F; Zhao Z; Li C; Liu T; Li W; Fu W
Medicine (Baltimore); 2016 Dec; 95(50):e5603. PubMed ID: 27977599
[TBL] [Abstract][Full Text] [Related]
32. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma.
Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
Cancer; 1998 Sep; 83(6):1094-101. PubMed ID: 9740073
[TBL] [Abstract][Full Text] [Related]
33. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia.
Polkowski WP; Skomra DG; Mielko J; Wallner GT; Szumiło J; Zinkiewicz K; Korobowicz EM; van Lanschot JJ
Eur J Surg Oncol; 2004 Dec; 30(10):1084-92. PubMed ID: 15522555
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis.
Amirghofran Z; Jalali SA; Hosseini SV; Vasei M; Sabayan B; Ghaderi A
J Gastrointest Cancer; 2008; 39(1-4):73-8. PubMed ID: 19333790
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD44v3, erythropoietin and VEGF-C in gastric adenocarcinomas: correlations with clinicopathological features.
Wang L; Li HG; Wen JM; Peng TS; Zeng H; Wang LY
Tumori; 2014; 100(3):321-7. PubMed ID: 25076245
[TBL] [Abstract][Full Text] [Related]
36. CD44 expression in benign and malignant colorectal polyps.
Neumayer R; Rosen HR; Reiner A; Sebesta C; Schmid A; Tüchler H; Schiessel R
Dis Colon Rectum; 1999 Jan; 42(1):50-5. PubMed ID: 10211520
[TBL] [Abstract][Full Text] [Related]
37. Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.
Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Cai SR; Ma JP
World J Gastroenterol; 2004 Mar; 10(6):776-82. PubMed ID: 15040016
[TBL] [Abstract][Full Text] [Related]
38. CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.
Okayama H; Kumamoto K; Saitou K; Hayase S; Kofunato Y; Sato Y; Miyamoto K; Nakamura I; Ohki S; Sekikawa K; Takenoshita S
Oncol Rep; 2009 Oct; 22(4):745-55. PubMed ID: 19724852
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of CD44 splice variants in human stage III cervical cancer.
Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
[TBL] [Abstract][Full Text] [Related]
40. Phagocytosis (cannibalism) of apoptotic neutrophils by tumor cells in gastric micropapillary carcinomas.
Barresi V; Branca G; Ieni A; Rigoli L; Tuccari G; Caruso RA
World J Gastroenterol; 2015 May; 21(18):5548-54. PubMed ID: 25987778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
